Abstract:As a commonly used implant material, calcium sulfate cement (CSC), has some shortcomings, including low compressive strength, weak osteoinduction capability, and rapid degradation. In this study, silica-based mesoporous materials such as SBA-15 were synthesized and combined with CSC to prepare CSC/SBA-15 composites. The properties of SBA-15 were characterized by X-ray diffraction, transmission electron microscopy, and nitrogen adsorption-desorption isotherms. SBA-15 was blended into CSC at 0, 5, 10, and 20 wt%, referred to as CSC, CSC-5S (5% mass ratio), CSC-10S (10% mass ratio), and CSC-20S (20% mass ratio), respectively. Fourier-transform infrared spectroscopy and compression tests were used to determine the structure and mechanical properties of the composites, respectively. The formation of hydroxyapatite on composite surfaces was analyzed using scanning electron microscopy and X-ray diffraction after soaking in simulated body fluid. BMP-2 was loaded into the composites by vacuum freeze-drying, and its release characteristics were detected by Bradford protein assay. The in vitro degradation of the CSC/SBA-15 composite was investigated by measuring weight loss. The results showed that the orderly, nanostructured, mesoporous SBA-15 possessed regular pore size and structure. The compressive strength of CSC/SBA-15 increased with the increase in SBA-15 mass ratio, and CSC-20S demonstrated the maximum strength. Compared to CSC, hydroxyapatite that formed on the surfaces of CSC/SBA-15 was uniform and compact. The degradation rate of CSC/SBA-15 decreased with increasing mass ratio of SBA-15. The adsorption of BMP-2 increased and released at a relatively slow rate; the release rate of BMP-2 in CSC-20S was the slowest, and presented characteristics of low doses of release. In vitro experiments demonstrated that the physical properties of pure CSC incorporated with SBA-15 could be improved significantly, which made the CSC/SBA-15 composite more suitable for bone repair and bone-tissue engineering.

Mesoporous Calcium-Silicon Xerogels with Mesopore Size and Pore Volume Influence Hmsc Behaviors by Load and Sustained Release of Rhbmp-2

Novel PCL-based Honeycomb Scaffolds As Drug Delivery Systems for Rhbmp-2

Sustained Release of Vh and Rhbmp-2 from Nanoporous Magnesium-Zinc-Silicon Xerogels for Osteomyelitis Treatment and Bone Repair

Biomimetic ECM coatings for controlled release of rhBMP-2: construction and biological evaluation

The Bio-Functional Role of Calcium in Mesoporous Silica Xerogels on the Responses of Osteoblasts in Vitro

Osteogenic evaluation of calcium/magnesium-doped mesoporous silica scaffold with incorporation of rhBMP-2 by synchrotron radiation-based μCT.

Preparation and physical characterization of calcium sulfate cement/silica-based mesoporous material composites for controlled release of BMP-2

Mesoporous silica rods with cone shaped pores modulate inflammation and deliver BMP-2 for bone regeneration

Calcium Phosphate Silicate Microspheres with Soybean Lecithin as a Sustained-Release Bone Morphogenetic Protein-Delivery System for Bone Tissue Regeneration.

In Vitro Degradability, Bioactivity And Primary Cell Responses To Bone Cements Containing Mesoporous Magnesium-Calcium Silicate And Calcium Sulfate For Bone Regeneration

Calcium sulfate hemihydrate/mineralized collagen for bone tissue engineering: In vitro release and in vivo bone regeneration studies

Sustained delivery of BMP-2 enhanced osteoblastic differentiation of BMSCs based on surface hydroxyapatite nanostructure in chitosan-HAp scaffold

Programmed Sustained Release of Recombinant Human Bone Morphogenetic Protein-2 and Inorganic Ion Composite Hydrogel As Artificial Periosteum

Chitosan/Nhac/Plga Microsphere Vehicle for Sustained Release of Rhbmp-2 and Its Derived Synthetic Oligopeptide for Bone Regeneration

In Situ Controlled Release Of Rhbmp-2 In Gelatin-Coated 3d Porous Poly(Epsilon-Caprolactone) Scaffolds For Homogeneous Bone Tissue Formation

Rhbmp-2-Loaded Calcium Silicate/Calcium Phosphate Cement Scaffold with Hierarchically Porous Structure for Enhanced Bone Tissue Regeneration

Incorporation of Calcium Sulfate Dihydrate into a Mesoporous Calcium Silicate/Poly-ε-Caprolactone Scaffold to Regulate the Release of Bone Morphogenetic Protein-2 and Accelerate Bone Regeneration

In vitro sustained release of recombinant human bone morphogenetic protein-2 microspheres embedded in thermosensitive hydrogels

MBG Scaffolds Containing Chitosan Microspheres for Binary Delivery of IL-8 and BMP-2 for Bone Regeneration.

In situ controlled release of rhBMP-2 in gelatin-coated 3D porous poly(ε-caprolactone) scaffolds for homogeneous bone tissue formation.

An injectable carboxymethyl chitosan-based hydrogel with controlled release of BMP-2 for efficient treatment of bone defects